Navegando por Assunto "Glioblastoma"

Agora exibindo 1 - 3 de 3

Acesso aberto (Open Access)
Análise in vitro do potencial antitumoral do conjugado LDE/Paclitaxel comparado à formulação do comercial Taxol sobre linhagem celular C6 de glioblastoma de rato
(Universidade Federal do Pará, 2022-09) ANJOS, Ana Carolina Brito dos Anjos; FRANCO, Edna Cristina Santos; http://lattes.cnpq.br/5939607544965550; https://orcid.org/0000-0003-2909-949X; LEAL, Walace Gomes; http://lattes.cnpq.br/2085871005197072
Glioblastoma, also known as grade IV astrocytoma, is one of the most common and aggressive types of tumors in the central nervous system. Among the characteristics of this type of tumor, the following stand out: infiltration of isolated tumor cells in normal brain tissue, cell proliferation, angiogenesis and intense necrosis. Currently, the main therapeutic approach consists of surgical resection followed by radiotherapy and chemotherapy. However, in most cases, the tumor is not well defined, spreading through the brain region, which makes it difficult to fully resection. In addition, the removal of tissue from this region can leave several sequels. Consequently, patients have high rates of recurrence and low rates of survival. Another problem in the treatment of this type of tumor is due to the lining of the blood-brain barrier that restricts the entry of molecules and substances, including drugs. Thus, this project aims to analyze the antineoplastic effects of the association of a nanoparticle called LDE with a structure similar to low-density lipoprotein (LDL) that will act as a carrier of the drug paclitaxel (PTX), commercially known as Taxol®, it is a chemotherapeutic drug whose cell antiproliferative action has been proven in the treatment of other types of cancer, such as breast and refractory ovarian cancers. For this purpose, the mouse glioblastoma cell line C6 was used for performing in vitro analysis regarding the effects of these treatments on aspects of viability, cytotoxicity and cell death by apoptosis, using the ApoTox-GloTM Triplex Assay kit (Promega Corporation), which performs the three previously mentioned analyses, sequentially. To evaluate growth and drug effect on PTX and LDE/PTX treatment groups, approximately 1x106 cells were cultured in 96-well microplates at concentrations of 0.01; 0.1; 1 and 10 μM in the times of 24h, 48h and 72h. The control was not exposed to the compounds, containing only DMEM culture medium. Results obtained after treatments with PTX and LDE/PTX were expressed as mean ± standard deviation and analyzed by one-way (cytotoxicity) and two-way (viability and apoptosis) ANOVA, followed by Tukey's post hoc test. Differences were considered significant when p ˂ 0.05.
Acesso aberto (Open Access)
Atividade antineoplásica da 1-desoxinojimiricina em modelos de câncer in vitro
(Universidade Federal do Pará, 2021-12) FONSECA, Suzanne Suely Santos da; PEREIRA JÚNIOR, Antônio; http://lattes.cnpq.br/1402289786010170; https://orcid.org/0000-0002-0808-1058
Cancer is one of the diseases that kill the most in Brazil, with alarming projections until 2030. In view of the problems related to cancer treatment, such as the compromise of healthy cells and, consequently, the presence of adverse effects, it is imperative to seek of alternative substances that may have antineoplastic effects and that are effective in the treatment of patients with this disease. In this way, the use of bioactive compounds has been widely used in the fight against neoplasms. Thus, the substance 1-deoxynojimyricin (1-DNJ) isolated from Bagassa guianensis may have great anticancer potential. In view of the problems related to cancer treatment, such as the impairment of healthy cells and, consequently adverse effects, it is necessary to search alternative substances that may have antineoplastic effects and they are effective in the treatment of patients with this disease. The objective of this study was to evaluate the effect of 1-deoxynojirimycin (1-DNJ) extracted from wood residue of the species Bagassa guianensis in different cancer cell lines to investigate possible antineoplastic actions in vitro using gastric adenocarcinoma and glioblastoma cancer cell lines. To do that, it was evaluated the effect of the substance 1-deoxynojirimycin on cell viability in vitro after 72h of treatment in cell lines ACP02 and A172. We also evaluated the effect of this bioactive compound on cell migration pattern, cell death by apoptosis and cell cycle changes using flow cytometry and reactive oxygen production. The results showed that 1-deoxynojirimycin makes a significant reduction in cell viability of cancer cell cultures in both glioblastoma (A172) and gastric cancer cell (ACP02) cell lines. The reduction in viability appears to be more effective in glioblastoma cell lines, with a common ic50 much lower when compared to other cell lines. We propose that the reduction in viability may be related to the decrease in reactive oxygen production in both lines after treatment with 1-DNJ. Besides that, 1-DNJ interrupts the cell cycle, prevents cell migration and induces necrosis-like cell death in the ACP02 lineage and apoptosis in the A172 lineage. Therefore, we suggest that 1-deoxynojirimycin may be an important and effective chemopreventive substance for the treatment of glioblastoma and gastric adenocarcinoma cancers.
Acesso aberto (Open Access)
Efeitos citotóxicos e mecanismo de ação da eleuterina isolada de Eleutherine plicata em modelo in vitro de células c6
(Universidade Federal do Pará, 2024-05) SHINKAI, Victória Mae Tsuruzaki; NASCIMENTO, José Luiz Martins do; http://lattes.cnpq.br/7216249286784978; https://orcid.org/0000-0003-3647-9124
Glioblastoma multiforme (GBM) is the most prevalent malignant primary tumor of the central nervous system (CNS). GBM cells are characterized by rapid proliferation and aggressive migration. There is growing demand for new therapies to treat this tumor, due to current therapeutic limitations. Quinone derivatives from plants have received increased interest as potential antiglioma drugs due to their diverse pharmacological activities such as inhibition of cell growth, inflammation, tumor invasion and promotion of tumor regression. The herb Eleutherine plicata, popularly known as Marupazinho, is widely used in popular medicine due to its pharmacological properties, containing quinone derivatives, more specifically naphthoquinones. Previous studies have demonstrated the antiglioma activity of Eleutherine plicata, which is related to three main naphthoquinone compounds – eleutherine, isoeleutherine and eleutherol – but mechanism of action remains unclear. Thus, the objective of this study was to investigate the potential cytotoxic and antiproliferative effect of eleutherin in an in vitro model of glioblastoma (C6 lineage). In vitro cytotoxicity was assessed by the MTT assay; Morphological changes were assessed by phase contrast microscopy. Apoptosis was determined by the annexin V-FITCpropidium iodide assay, and antiproliferative effects were assessed by the colony formation assay. Protein kinase B (AKT/pAKT) expression was measured by western blot, and telomerase reverse transcriptase mRNA was measured by quantitative real-time polymerase chain reaction (qRT-PCR). The results obtained indicated that eleutherin, isolated from the Hexanic fraction, had a cytotoxic effect on the C6 lineage. Structural changes were observed by image capture, with a significant reduction in colony formation, induction of apoptosis, inhibition of pAKT and reduction in telomerase expression after treatment. Thus, our study showed that the eleuterin molecule has cytotoxic activity in C6 lineage glioma.